Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP
The results were consistent across both the 10 mg and 40 mg treatment arms
TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
The acquisition adds VYKAT XR (diazoxide choline), the first FDA-approved therapy for hyperphagia in Prader-Willi syndrome (PWS), a rare genetic disorder, to Neurocrine’s portfolio
The trial also demonstrated significant improvements across multiple secondary endpoints
Subscribe To Our Newsletter & Stay Updated
